• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    PanTher Therapeutics Gets FDA Clearance For PTM-101 Phase 1b Study

    BUSINESSWIRE

    PanTher Presents Positive Data for PTM-101 in Pancreatic Cancer at AACR

    BUSINESSWIRE

    PanTher Therapeutics Awarded $14.2M from CPRIT

    BUSINESSWIRE

    PanTher Initiates Dosing in Phase 1 Trial of PTM-101 for Pancreatic Cancer

    BUSINESSWIRE

    PanTher Receives Ethics Approval to Initiate Phase 1 Clinical Trial of PTM-101

    BUSINESSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.